Dr. Zeng Li is an Associate Professor and Principal Investigator at National Neuroscience Institute, Singapore. She earned her BSc in Biology from Beijing Normal University, and a Ph.D. in Biochemistry from University of Glasgow, followed by postdoctoral training in Signal Transduction group at IMCB. She later joined IMCB’s Developmental Biology group as a Research Scientist where she investigated TAG1-APP signalling in neurogenesis and AD.
Since establishing her research team at NNI in 2009, Dr Zeng has held several academic appointments, including Associate Professor at Duke-NUS NBD programme and Adjunct Associate Professor at LKCmedicine. She currently serves as Deputy Director for Basic Science & Translational Research at NNI.
Her laboratory focuses on translational research in neurodegenerative diseases, collaborating closely with clinicians to unravel the neuro-pathophysiology crosstalk between AD and PD. Notable discoveries include NOTCH2NLC GGC intermediate repeat expansion induces early PD-like phenotypes in NOTCH2NLC Repeat Expansion Associated Disorders (NREDs) (PMC11603791); identifying MSR1-mediated phagocytosis as a common feature across multiple dementia subtypes (PMC12359983); discovering APP/AICD-LRRK2 as a common vicious loop in AD and PD (Science Sig2022), developing drugs targeting the APP/AICD-LRRK2 loop to reverse the neurotoxicity for the treatment of PD (Science Sig2017). Her research employs pre-clinical mouse model, 2D iPSCs and 3D brain organoids derived from neurogenetics patients to elucidate the causes of neurodegeneration and develop novel therapeutic interventions for neurodegenerative diseases.